Fingolimod
Fingolimod is a pharmaceutical drug with 57 clinical trials. Currently 8 active trials ongoing. Historical success rate of 84.2%.
Success Metrics
Based on 32 completed trials
Phase Distribution
Phase Distribution
6
Early Stage
9
Mid Stage
33
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
78.0%
32 of 41 finished
22.0%
9 ended early
8
trials recruiting
57
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
A Study to Learn About the Safety of Diroximel Fumarate (DRF) and Dimethyl Fumarate (DMF) and Their Effects on Relapses in Pediatric Participants With Relapsing Forms of Multiple Sclerosis (RMS)
Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple Sclerosis
Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of Multiple Sclerosis
Clinical Trials (57)
Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
A Study to Learn About the Safety of Diroximel Fumarate (DRF) and Dimethyl Fumarate (DMF) and Their Effects on Relapses in Pediatric Participants With Relapsing Forms of Multiple Sclerosis (RMS)
Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple Sclerosis
Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of Multiple Sclerosis
A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis (RRMS)
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
A Study to Learn More About The Safety of Diroximel Fumarate (VUMERITY®) in Participants Who Took it During Pregnancy And About the Health of Their Babies
Fingolimod for Type 2 Diabetes Mellitus
Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation
Fingolimod as a Treatment of Cerebral Edema After Intracerebral Hemorrhage
The Gilenya Pregnancy Registry
Examining the Risk of Skin Cancer in Multiple Sclerosis Patients Using Fingolimod: a Population-Based Study
Safety and Effectiveness of Generic Fingolimod (Sphingomod®, Hikma) in Patients With Relapsing-Remitting Multiple Sclerosis in Egypt
Fingolimod in Minimal Invasive Treatment of Intracerebral Hemorrhage
Fingolimod in Treating Patients With Chemotherapy-Induced Neuropathy
Fingolimod in Preventing Paclitaxel-Associated Neuropathy in Patients With Breast Cancer
Combinating Fingolimod With Alteplase Bridging With Thrombectomy in Acute Ischemic Stroke
Relationship Between Oral DMT Burden and Adherence in MS
Fingolimod in Endovascular Treatment of Ischemic Stroke
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 57